Rani Therapeutics Holdings (RANI) Debt Ratio (2020 - 2025)

Rani Therapeutics Holdings' Debt Ratio history runs 6 years deep, the most recent figure standing at 1.34 for Q3 2025.

• On a quarterly basis, Debt Ratio rose 105.38% year-over-year to 1.34 in Q3 2025; TTM through Sep 2025 was 1.34, a 105.38% increase from a year earlier, with the FY2024 full-year figure at 0.67, up 32.44% from the prior year.
• Debt Ratio grew to 1.34 in Q3 2025 per RANI's latest filing, from 1.02 in the prior quarter.
• Across five years, Debt Ratio topped out at 1.34 in Q3 2025 and bottomed at 0.0 in Q2 2022.
• The 5-year median for Debt Ratio is 0.38 (2023), against an average of 0.43.
• Across the five-year window, Debt Ratio plunged 99.43% in 2022 and jumped 121791.07% in 2023, its largest moves.
• Year by year, Debt Ratio stood at 0.0 in 2021, then jumped by 26499.1% to 0.27 in 2022, then jumped by 88.01% to 0.51 in 2023, then surged by 32.44% to 0.67 in 2024, then soared by 98.72% to 1.34 in 2025.
• Per Business Quant, the three latest RANI Debt Ratio figures stand at 1.34 (Q3 2025), 1.02 (Q2 2025), and 0.87 (Q1 2025).